diabetestalk.net

Abbott Flash Glucose Monitoring System India

Healthcare Firm Abbott Launches Glucose Monitoring System For Diabetes

Healthcare Firm Abbott Launches Glucose Monitoring System For Diabetes

Healthcare firm Abbott launches glucose monitoring system for diabetes Abbott today launched the professional version of its flash glucose monitoring system, which will help doctors personalise treatment plans for diabetes patients. MUMBAI: Global healthcare firm, Abbott today launched the professional version of its flash glucose monitoring system, which will help doctors personalise treatment plans for diabetes patients. "Abbott has chosen India as the first country globally to launch this technology. The glucose assessment tool will cost Rs 1,999 for 14-days, will empower doctors to help their patients manage their diabetes effectively," Abbott Diabetes Care R&D Director Matthew Bates told reporters here. India, now carries 20 per cent of the global burden of diabetes. "The glucose monitoring system continuously measures glucose in interstitial fluid through a small filament that is inserted under the skin. It records glucose levels every 15 minutes, capturing up to 1,340 glucose readings over 14 days, thus giving the treating doctor comprehensive data for a complete glucose profile of their patient," Bates said. After 14 days the doctor uses a flash glucose monitoring reader to scan the sensor and download the glucose results. This data can help doctors to make more informed treatment decisions. "There is a significantly high number of people with diabetes in India who have poor sugar control despite everything that they do to control it," said Shashank Joshi, President, Association of Physicians of India and a leading biabetologist said. "Current diabetes monitoring tools are limited since they do not reveal a complete picture of glucose fluctuations that a person goes through during a day. The reports from Abbott's Flash Glucose Monitoring System provide me with Continue reading >>

Home Abbott

Home Abbott

How do HCPs discard the disposable components, for example sensor pack and applicator? Flash glucose monitoring is an easy way to generate the dense glucose data needed for a complete glycaemic picture. What makes flash glucose monitoring unique is the quick scan of the reader over the sensor to collect glucose data. Another key feature of a flash glucose monitoring system is the small and fully disposable sensor that lasts up to 14 days, requires no calibration, no routine finger pricks*, and automatically measures, captures and stores glucose data. *A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycaemia or impending hypoglycaemia is reported by the System or when symptoms do not match the System readings. ISF is a reasonable alternative for blood. Glucose can be measured in the ISFthe fluid around the bodys cells where glucose freely diffuses from capillaries to the interstitial space.* *Rebrin K, Steil GM. Can interstitial glucose assessment replace blood glucose measurements? Diabetes Technol Ther. 2000;2(3):461-472. The FreeStyle Libre Pro Flash Glucose Monitoring System is a glucose-monitoring device indicated for detecting trends and tracking patterns in persons (age 18 and older) with diabetes. The system is intended for use by healthcare professionals. Readings from the FreeStyle Libre Pro Flash Glucose Monitoring System are not made available directly to patients in real time. The FreeStyle Libre Pro Flash Glucose Monitoring System aids in the detection of episodes of hyperglycaemia and hypoglycaemia, facilitating therapy adjustments. Interpretation of the FreeStyle Libre Pro Flash Glucose Monitoring S Continue reading >>

Flash Glucose Monitoring: The Future Is Here

Flash Glucose Monitoring: The Future Is Here

Flash Glucose Monitoring: The Future Is Here 1University of Colorado, Denver School of Medicine, Aurora, Colorado. 2Barbara Davis Center for Diabetes - Adult Clinic, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 1University of Colorado, Denver School of Medicine, Aurora, Colorado. 2Barbara Davis Center for Diabetes - Adult Clinic, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 1University of Colorado, Denver School of Medicine, Aurora, Colorado. 2Barbara Davis Center for Diabetes - Adult Clinic, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Address correspondence to:, Satish K. Garg, MD, Barbara Davis Center for Diabetes - Adult Clinic, 1775 Aurora Court, A140, Aurora, CO 80045, E-mail:Email: [email protected] This article has been cited by other articles in PMC. We cannot believe that it has been more than two decades since we first evaluated real-time continuous glucose monitoring (CGM)(GlucoWatch) in patients with type 1 diabetes (T1D). The first real-time CGM (GlucoWatch), which uses a reversed iontophoresis to measure interstitial glucose, was approved to be used for 12 h by the Food and Drug Administration (FDA) in 1999. 1 , 2 Since then, several advancements have led to the availability of many CGM systems MiniMed iPro, Enlite 2, Enlite Enhanced, Enlite 3 (Medtronic, Northridge, CA), DexCom STS (Short Term Sensor), Dexcom 3, 7, Gen 4 and 5 (Dexcom, San Diego, CA), and Navigator (Abbott Diabetes Care, Alameda, CA). 3 , 4 All of the CGMs were approved as adjunctive and needed 24 calibrations a day. 3 , 4 Bailey et al. highlighted the accuracy of CGMs and clinical implications of accuracy in this supplement. 5 Most recently, for the first time, Dexcom Gen 5 was approved as nonadjunctive, and CGM data Continue reading >>

News Media | Abbott U.s. | Abbott Recognized With Innovation Award

News Media | Abbott U.s. | Abbott Recognized With Innovation Award

FAST COMPANY HONORS ABBOTT AMONG THE MOST INNOVATIVE BUSINESSES Fast Company has named Abbott to its annual list of most innovative companies, placing us among the Top 10 businesses in Biotech. In naming its most innovative companies, Fast Company is "honoring leading enterprises and rising newcomers that exemplify the best in nimble business and impactful innovation." Winners this time include Amazon, Apple, Facebook, Netflix. To produce the 2017 list, Fast Company reporters surveyed thousands of enterprises across the globe to identify the most notable innovations of the year and trace the impact of those initiatives on business, industry, and the larger culture. The coverage also highlights Top 10 lists in 36 sectors and geographies, from artificial intelligence to health to travel. This section of our guiding anthem is particularly appropriate today: "Abbott has long been in the business of life. Creating more possibilities for more people through the power of health. But this business is not about reflecting on past achievements. It is about relentlessly pursuing new ones." *FREESTYLE LIBRE & FREESTYLE LIBRE PRO: Abbotts new sensing technology, FreeStyle LibreTM and FreeStyle LibreTM ProTM systems are in many ways the devices people with diabetes have been waiting for. Both devices are factory-calibrated and provide users and the healthcare professionals with data that enable better diabetes management. FreeStyle Libre system is currently available across 32 countries globally and is currently under review in the U.S. (pending FDA approval and not available for sale in the U.S.); FreeStyle Libre Pro system is available in India, South Africa and the U.S. TO LEARN MORE ABOUT FREESTYLE LIBRE PRO, PLEASE CLICK HERE . ALINITY: Diagnostic testing influences as much as Continue reading >>

Abbott Launches Innovative Blood Glucose Monitoring System - Business Line

Abbott Launches Innovative Blood Glucose Monitoring System - Business Line

Abbott launches innovative blood glucose monitoring system Multinational pharmaceutical company Abbott has rolled out its professional version of the Flash Glucose Monitoring System. A glucose assessment tool, it takes a more focused approach to diabetes management by putting the doctor in charge, explains Matthew Bates, Director (Research and Development), Abbott Diabetes Care. The Flash Glucose Monitoring System consists of a small, round sensor (about the size of a 10 coin). A doctor applies this water-resistant and disposable sensor on the back of the upper arm of a person with diabetes. The sensor has a self-adhesive pad and stays in place for 14 days, requiring no patient interaction with the sensor or finger-prick calibration, Abbott explained. The system continuously measures glucose in interstitial fluid through a small (5mm long, 0.4mm wide) filament that is inserted just under the skin. It records glucose levels every 15 minutes, capturing up to 1,340 glucose readings over two weeks, giving the treating doctor a complete glucose profile of their patient, it added. The data picked up by the sensor is read by the doctors using a reader, which looks like a mobile phone. The monitoring system costs 1,999 and is to be purchased by the person with diabetes, while the reader, just shy of 5,000, is to be purchased by the doctor. Explaining the difference in approaching the India market, compared to the European market where it was launched late last year, Bates said it matched the professional system sold to doctors in Europe. So the reader with the doctor can read multiple patients readings, unlike a consumer version where the reader is calibrated to the individuals readings. Senior endocrinologist Shashank Joshi said the product was useful in giving the doctor a g Continue reading >>

Evolution Of Glucose Monitoring: From Glucose Monitors To The Ambulatory Gucose - Innovatiocuris

Evolution Of Glucose Monitoring: From Glucose Monitors To The Ambulatory Gucose - Innovatiocuris

EVOLUTION OF GLUCOSE MONITORING: FROM GLUCOSE MONITORS TO THE AMBULATORY GUCOSE Evolution of Glucose Monitoring: From Glucose Monitors to the Ambulatory Glucose Dr. Jothydev Kesavadev, Chairman & Managing Director at Jothydevs Diabetes Research Centre, Kerala, India. He completed his M.B.B.S and MD from India and fellowship in Endocrinology training at Mayo clinic, USA and FRCP from London and Glasgow. He pioneered in publishing Consensus guidelines on insulin pump, glucose monitoring and vaccination in diabetes for India. Gopika Krishnan, B Pharm, Msc, and Academic Head at Jothydevs Diabetes Research Centre, Trivandrum, Kerala, India. Glucose Monitoring has been around as a valuable tool since many years. However in spite of many advances, there have been important shortcomings of the current tools we have. The HbA1c is a highly validated and researched tool however, it only provides an 90 day retrospective average of a patients glucose and gives no major in-depth analysis of their glucose profile. One can use the self-monitoring tools and lab test to obtain their glucose profile but testing strip costs and finger stick blood pricks and pain limits their usability in patients. It is widely known that continuous glucose monitoring systems (CGMS) provide the best data for analysis, but its duration is too short or too cumbersome and costly for use in routine practice. In this regards the new tool, FreeStyle Libre Pro and its software reports that provide the Ambulatory Glucose Profile (AGP) is easy to use, and provides the complete glucose profile of a patient so that a doctor can make informed treatment decisions. It is an exciting time for Diabetes, with many new innovations in the pipeline that can ease the hurdles associated with proper monitoring. Monitoring glucos Continue reading >>

Fda Clears Abbotts Needle-free Cgm For Professional Use

Fda Clears Abbotts Needle-free Cgm For Professional Use

FDA Clears Abbott's Needle-Free CGM For Professional Use FDA has approved Abbotts Freestyle Libre Pro System for professional continuous glucose monitoring (CGM), which provides clinicians with 14 days worth of patient data so they can make more informed clinical decisions regarding diabetes management. The system does not require finger-stick calibrations and is significantly more affordable than competitive CGM models, stated Abbott. The FreeStyle Libre Pro sensor is attached to the back of the patients upper arm at the doctors office. A water-resistant adhesive pad holds the sensor in place and a 5 mm long filament inserted under the skin monitors blood glucose every fifteen minutes for a total of 1340 glucose measurements in 14 days. After two weeks, the patient returns to the doctors office, where a clinician scans the sensor with an external reader and downloads the data. The key advantages of the FreeStyle Libre Pro system, according to Abbott, are its ease of use and reduced equipment costs. Once the sensor is in place, the patient does not need to interact with it or take home any cumbersome scanning equipment that may require recharging or maintenance. Also, a doctors office can purchase one reader and use it to scan multiple patients using the system. Inconsistent self-monitoring makes ongoing diabetes management difficult, because there are too many gaps in the data, said Eugene Wright, a doctor at the Duke Southern Regional Area Health Education Center. Wright called the new technology a change to the paradigm, because it makes professional CGM more accessible and affordable for Type I patients. While the professional model of the FreeStyle Libre is approved for the U.S., the consumer version of the technology remains under review at the FDA. Earlier this Continue reading >>

A Review Of The Freestyle Libre Flash Glucose Monitor

A Review Of The Freestyle Libre Flash Glucose Monitor

A review of the Freestyle Libre flash glucose monitor I have had for some reason(not yet diagnosed), frequent episodes of low sugar without being a diabetic for over a decade now. In March 2015, I went to an endocrinologist recommended by a friend, saw the doctors reviews on practo.com were decent, set up an appointment. After a few consultations with the doctor, I was recommended to try the Abbott Freestyle flash glucose monitoring system to figure out what was actually going on with my blood sugars. Abbott launched the Flash glucose sensor in India in Feb 2015. Was one of the first few patients who got to trial it out. The cost at the time was Rs 4500 for the sensor (Update- MRP of the sensor is Rs 1999) The reader (Rs 5000) is separate and is usually owned by the doctor or medical rep. Open the box, attach the sensor to the applicator and attach it to the underside of your upper left arm. It remains attached for 2 weeks, after which it stops taking readings. While it is attached, it takes readings every 15min and stores it. Once you want to download the readings, you bring the reader close to the sensor and all the data is downloaded to the reader. You can view the readings on the reader itself or transfer it to the computer. Thats it. This is so much more convenient than attaching a CGM (continuous glucose monitor) to your belly for 2 weeks and having to calibrate it every day or so. Even when attaching the monitor to my upper arm, I thought it would be painful but in fact, I didnt hurt at all. The FPM is actually accurate. Most readings were within 5-10 % of actual readings(checked with a glucose monitor (Bayer Contour TS.) The glue on the pad that attached to your skin can cause allergies to some people over repeated usage. Rs 4500 for every 2 weeks of monitoring Continue reading >>

Evaluation Of Freestyle Libre Flash Glucose Monitoring System On Glycemic Control, Health-related Quality Of Life, And Fear Of Hypoglycemia In Patients With Type 1 Diabetes

Evaluation Of Freestyle Libre Flash Glucose Monitoring System On Glycemic Control, Health-related Quality Of Life, And Fear Of Hypoglycemia In Patients With Type 1 Diabetes

Evaluation of FreeStyle Libre Flash Glucose Monitoring System on Glycemic Control, Health-Related Quality of Life, and Fear of Hypoglycemia in Patients with Type 1 Diabetes Ayman A Al Hayek , Asirvatham A Robert , and Mohamed A Al Dawish Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia Ayman A Al Hayek, Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, P.O. Box 7897, Riyadh 11159, Saudi Arabia. Email: [email protected] Received 2017 Sep 18; Accepted 2017 Nov 9. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ( ) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ( ). In the current era of modern technology and the development of smart devices such as the flash glucose monitoring (FGM) systems, patients can easily monitor their glucose levels more frequently without any inconvenience. In this study, we evaluate the effect of FreeStyle Libre FGM system on glycemic control, hypoglycemia, health-related quality of life (QoL), and the fear of hypoglycemia (FOH) among children and young people with type 1 diabetes (T1D). A prospective study was conducted at the Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia, between January 2017 and May 2017 on 47 (aged 13-19 years) registered patients with T1D who used conventional finger-pricking method for self-testing the glucose. At baseline visit, the FGM sensors were placed on each participant by a trained diabetes educator. The data collected from the sensors were Continue reading >>

Fda Approves Abbott's Blood Glucose Monitoring Device

Fda Approves Abbott's Blood Glucose Monitoring Device

(Reuters) - The U.S. Food and Drug Administration said it approved Abbott Laboratories’ glucose monitoring device for adults with diabetes, allowing millions of people to track their blood sugar levels without having to prick their fingers. Abbott's FreeStyle Libre Flash reduces the need for fingerstick testing, which is painful and inconvenient, by inserting a small sensor wire below the skin to continuously measure and monitor glucose levels. The device can be worn for up to 10 days. (bit.ly/2xxbrbt) Chicago-based Abbott’s shares were trading up 3.6 percent at $54 after the bell on Wednesday. Traditionally, diabetes patients measured their glucose levels nearly a dozen times a day by pricking their finger tips for blood samples. Nowadays, advanced continuous glucose monitoring devices, such as DexCom Inc’s G5 Mobile and Medtronic Plc’s iPRO2 Professional, which have sensors to measure glucose readings are used. However, these devices require fingertip testing two to four times a day for optimal accuracy. DexCom’s shares were down 14.3 percent at $57.85, while Medtronic’s stock rose marginally in after-market trading. Most diabetes patients do not measure glucose as often as they should because of the discomfort caused by these kinds of tests, Jared Watkin, senior vice president of Abbott’s Diabetes Care unit, told Reuters. According to studies, the majority of people with diabetes test glucose levels less than three times a day, Abbott said. Abbott’s device, however, is a long-lasting glucose sensor, which does not require fingerstick testing to ensure its accuracy. The company plans to launch the device before the end of this year, Watkin said on Wednesday. Abbott already has a continuous glucose monitoring device called FreeStyle Libre Pro in the Uni Continue reading >>

Press Release | Abbott India | Abbott Launches Freestyle Libre Pro In India

Press Release | Abbott India | Abbott Launches Freestyle Libre Pro In India

First-of-its-Kind Flash Glucose Monitoring System from Abbott to Revolutionize Diabetes Management in India GLUCOSE ASSESSMENT TOOL FROM ABBOTT WILL EMPOWER DOCTORS TO HELP THEIR PATIENTS MANAGE THEIR DIABETES EFFECTIVELY SOFTWARE PRESENTS DATA IN A USER-FRIENDLY, VISUAL CHART, ENABLING PRODUCTIVE TREATMENT DISCUSSIONS INDIA IS THE FIRST COUNTRY GLOBALLY TO LAUNCH THIS TECHNOLOGY* Mumbai, 16 June 2015 If you have diabetes or know of someone who does, you know the importance of living your life normally with vitality and achieving the important goal of preventing long term complications of diabetes. Abbott today launched the professional version of its Flash Glucose Monitoring System, a transformative glucose monitoring technology for people with diabetes. The Flash Glucose Monitoring System is a glucose assessment tool that fundamentally changes how doctors can personalize their patient's diabetes treatment plans thus allowing patients to better manage their disease. "India now carries 20 percent of the global burden of diabetes," said Robert Ford, senior vice president, Diabetes Care, Abbott. "There is an immense need to help people in India better manage their diabetes, enabling them to live healthier lives. Abbott's Flash Glucose Monitoring System is designed to empower doctors in India to help their patients through rich data and actionable insights." Abbotts Flash Glucose Monitoring System consists of a small, round sensor slightly larger than a 10 rupee coin. A doctor applies the discreet, water-resistant1 and disposable sensor on the back of the upper arm of a person with diabetes. The sensor is held in place with a self-adhesive pad and remains on the back of the arm for up to 14 days, requiring no patient interaction with the sensor or finger-prick calibration Continue reading >>

India Oks Abbott's Freestyle Libre Pro Glucose Monitoring System - Massdevice

India Oks Abbott's Freestyle Libre Pro Glucose Monitoring System - Massdevice

Home India OKs Abbotts FreeStyle Libre Pro glucose monitoring system India OKs Abbotts FreeStyle Libre Pro glucose monitoring system Regulators in India approved a glucose monitoring system made by Abbott (NYSE: ABT ) thats designed to track patients blood sugar levels for up to 2 weeks. Abbott said India is the 1st country to approve the FreeStyle Libre Pro Flash professional-use device, which uses a patient-worn sensor to track blood glucose levels for up to 14 days. The sensor is applied by a healthcare provider to the back of the upper arm, measuring glucose levels every 15 minutes in interstitial fluid via a small filament inserted just under the skin, the Abbott Park, Ill.-based company said. Data from the FreeStyle Libre Pro Flash can be wirelessly downloaded at the providers office in about 5 seconds,. Abbott said . The system is the 2nd in Abbotts Flash glucose monitoring line, following a personal-use version called FreeStyle Libre that launched in Europe last fall. The FreeStyle Libre Pro system is slated to launch in 6 Indian cities including Mumbai, Delhi, Chennai, Bangalore, Pune and Trivandrum "in the coming weeks," Abbott said. Abbott diabetes care senior vice president Robert Ford said India carries 20% of the global burden of diabetes, citing the "immense need" there for better management tools for patients. "Abbotts FreeStyle Libre Pro system is designed to empower doctors in India to help their patients through rich data and actionable insights," Ford said in prepared remarks. "Current systems for continuous measurement of glucose are cumbersome and require regular finger-pricking to ensure they are calibrated correctly for accuracy," added technical operations division vice president Jared Watkin. "Based on insights from our c Continue reading >>

First-of-its-kind Diabetes Technology Revolutionizes How Glucose Data Is Collected And Analyzed For People In India

First-of-its-kind Diabetes Technology Revolutionizes How Glucose Data Is Collected And Analyzed For People In India

First-of-its-Kind Diabetes Technology Revolutionizes How Glucose Data is Collected and Analyzed for People in India - ABBOTT RECEIVES APPROVAL IN INDIA FOR FREESTYLE LIBRE PRO FLASH GLUCOSE MONITORING SYSTEM - INDIA IS FIRST COUNTRY TO LAUNCH NEW PROFESSIONAL-USE DEVICE, DESIGNED TO HELP DOCTORS TREAT PATIENTS WITH DIABETES - SYSTEM MEASURES GLUCOSE LEVELS THROUGH SMALL SENSOR ON THE BACK OF THE UPPER ARM Apr 02, 2015, 09:00 ET from Abbott ABBOTT PARK, Ill., April 2, 2015 /PRNewswire/ --India has the third highest population of obesity, trailing only the United States and China.[1] Nutrition, lifestyle and demographic transitions in India have led to a decline in overall health[2]and for many, that also means a rise in diseases such as diabetes. To provide tools to better manage diabetes, Abbott(NYSE: ABT)has launched the FreeStyle Libre Pro Flash Glucose Monitoring System in Indiaa transformative new glucose monitoring tool that fundamentally changes how doctors treat people with diabetes. With this tool, doctors can get the comprehensive glucose data they need to make more informed treatment decisions. They can personalize their patient's diabetes treatment plans, allowing people to better manage their disease. According to the International Diabetes Federation, India today has a diabetes population of 65.1 million compared to 50.8 million in 2010[3]. A recent survey conducted by the Association of Physicians of India (API) and sponsored by Abbott[4]showed that 90 percent of people surveyed with uncontrolled diabetes [HbA1c level higher than 7 percent] in India continue to believe that they have control over their glucose levels, despite facts suggesting otherwise. "India now carries 20 percent of the global burden of diabetes," said Robert Ford, senior vice presiden Continue reading >>

Freestyle Libre Glucose Monitoring System | Singapore

Freestyle Libre Glucose Monitoring System | Singapore

Now you can check your glucose with a painless5 The FreeStyle Libre system liberates you from the hassles of routine finger pricking. Just scan the reader over the small sensor worn on the back of your upper arm to check your glucose. *Images and readings are for illustration purpose only 1 Scanning the sensor to obtain glucose values does not require lancets. 2A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycaemia or impending hypoglycaemia is reported by the system or when symptoms do not match the system readings. 3A caregiver at least 18 years old is responsible for supervising, managing, and assisting the child in using the FreeStyle Libre system and interpreting its readings. 4Edge, Julie., et al. An alternative sensor-based method for glucose monitoring in children and young people with diabetes. Archives of Disease in Childhood 102.6 (2017): 543-549. 5Most people did not feel any discomfort under the skin while wearing the FreeStyle Libre sensor. In a study conducted by Abbott Diabetes Care, 93.4% of patients surveyed (n=30) strongly agree or agree that while wearing the sensor, they did not feel any discomfort under their skin. [29 persons have finished the study; 1 person terminated the study after 3 days due to skin irritations in the area where the sensor touched the skin]. Each FreeStyle Libre sensor is painless to apply, easy to use (for up to 14 days) and water resistant6. 6Sensor is water resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes. You can do it anytime. Get glucose readings with a painless one-second scan, even through clothing7. 7The FreeStyle Libre read Continue reading >>

Worksmart Asia: Abbott Brings Freestyle Libre Pro System For Glucose Monitoring To India

Worksmart Asia: Abbott Brings Freestyle Libre Pro System For Glucose Monitoring To India

Abbott brings Freestyle Libre Pro System for glucose monitoring to India The prevalence of type II diabetes is increasing in young adults in Asia, according to research from the Asia Diabetes Foundation (ADF). The ADF has funded research* together with Merck showing that 18% of the people recruited into its Joint Asia Diabetes Evaluation (JADE) study from nine Asian countries and territories were under the age of 40 when they were diagnosed with diabetes, a condition called young-onset diabetes. While Merck offers a drug called Janumet XR to addresstype IIdiabetes, Abbott is tackling the treatment of the disease with a wearable that offers doctors more insights into patients' blood glucose levels over the long term. Source: Abbott website. The FreeStyle Libre System at work. The FreeStyle Libre Pro System is designed to be used by healthcare professionals, rather than by patients themselves. "India now carries 20% of the global burden of diabetes," said Robert Ford, Senior VP, Diabetes Care, Abbott. "There is an immense need for people in India to better manage their diabetes, enabling them to live healthier lives. Abbott's FreeStyle Libre Pro System is designed to empower doctors in India to help their patients through rich data and actionable insights." The FreeStyle Libre Pro Flash Glucose Monitoring System consists of a small, round sensorslightly larger than a 10 rupee coin (the size of a US quarter). A healthcare professional applies the sensor on the back of the patient's upper arm. The sensor is held in place with a self-adhesive pad and remains on the back of the arm for up to 14 days, requiring no patient interaction. When applied to the skin, the sensor continuously measures glucose in interstitial fluid through a small (5mm long, 0.4mm wide) filament that i Continue reading >>

More in blood sugar